Stay updated with breaking news from Medical Optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Metformin plus insulin therapy vs placebo was not associated with reduced neonatal adverse outcomes among type 2 and gestational diabetes patients.
In this episode, hosts breakdown as pair of recent studies examining management of diabetes during pregnancy.
Results from the MOMPOD RCT indicate metformin added to insulin did not reduce the frequency of a composite adverse neonatal outcome in pregnant adults with diabetes.